metomidate
{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459444292
| IUPAC_name = methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
| image = Metomidate.svg
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 5377-20-8
| ATCvet = yes
| ATC_prefix = N05
| ATC_suffix = CM94
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Z18ZYL8Y51
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 494039
| PubChem = 21474
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 20182
| C = 13 | H = 14 | N = 2 | O = 2
| smiles = O=C(OC)c1cncn1C(c2ccccc2)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C13H14N2O2/c1-10(11-6-4-3-5-7-11)15-9-14-8-12(15)13(16)17-2/h3-10H,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FHFZEKYDSVTYLL-UHFFFAOYSA-N
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| pregnancy_category =
| legal_status = Rx-only
| routes_of_administration =
}}
Metomidate is a non-barbiturate imidazole that was discovered by Janssen Pharmaceutica in 1965BE Patent 662474 and under the names (Hypnodil, Nokemyl) is sold as a sedative-hypnotic drug used in Europe to treat humans and for veterinary purposes.{{cite book | title = Index nominum 2000: international drug directory | url = https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA683 | access-date = 27 October 2011 | year = 2000 | publisher = Taylor & Francis US | isbn = 978-3-88763-075-1 | pages = 683}}
11C-labelled metomidate (11C-metomidate), may be used with positron emission tomography (PET). For instance, to detect tumors of adrenocortical origin.{{cite journal | vauthors = Khan TS, Sundin A, Juhlin C, Långström B, Bergström M, Eriksson B | title = 11C-metomidate PET imaging of adrenocortical cancer | journal = European Journal of Nuclear Medicine and Molecular Imaging | volume = 30 | issue = 3 | pages = 403–10 | date = March 2003 | pmid = 12634969 | doi = 10.1007/s00259-002-1025-9 | s2cid = 23744095 }}{{cite journal | vauthors = Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Långsjö J, Salmi J, Välimäki M, Någren K, Nuutila P | display-authors = 6 | title = Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG | journal = Journal of Nuclear Medicine | volume = 45 | issue = 6 | pages = 972–9 | date = June 2004 | pmid = 15181132 | url = http://jnm.snmjournals.org/cgi/content/full/45/6/972 }}
See also
References
{{Reflist|2}}
{{Hypnotics}}
{{General anesthetics}}
{{GABAAR PAMs}}
Category:11β-Hydroxylase inhibitors
Category:GABAA receptor positive allosteric modulators
{{sedative-stub}}